Sibel Health Raises $33M in Series B Funding
Summary
Sibel Health, a Niles, IL-based medical technology company spun out of the John Rogers Research Group and the Querrey Simpson Institute for Bioelectronics at Northwestern University, closed a $33m Series B financing round. The company intends to use the funds to scale up its FDA-cleared ANNE® One platform for global deployments across the entire continuum of care from the home to the hospital. This has been driven by partnerships with leading Fortune 500 companies and funding support from the U.S. military, the National Institutes of Health, and the Bill & Melinda Gates Foundation. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, PhD, a world expert in advanced body-worn sensors and previously the CTO and cofounder of toSense and Sotera, joins as president from Baxter International.